ANIX
Anixa Biosciences Inc
2.90$
-1.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | -120.7% | – | – | -51.7% | -491.8% | – | – | -100.0% | – | – | – | – | – | – | -100.0% | – | – | -100.0% | – | – | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.1% | -89.4% | +62,623.1% | -127.6% | – | +1,874.8% | -51.8% | -99.5% | +0.0% | +13,416.3% | -100.0% | – | – | – | – | – | +209.6% | -96.2% | +3.6% | +2,439.1% | -97.4% | +10.0% | -9.1% | +10.0% | +0.0% | +1,363.6% | -93.2% | +9.1% | +8.3% | -7.7% | -75.0% | -100.0% | – | – | +0.0% | +0.0% | +11.1% | – | – | – | |
| – | -101.7% | – | – | -82.4% | -165.1% | – | -51.3% | -101.0% | – | – | -100.0% | – | – | – | – | – | – | -111.4% | – | – | -100.3% | – | – | – | -100.0% | – | -122.4% | – | -109.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.2% | -4.5% | -15.8% | -3.1% | +121.1% | -15.1% | +345.6% | -17.3% | -7.6% | -43.5% | -14.5% | -21.1% | +74.0% | -17.6% | -30.1% | +93.0% | -50.1% | +23.5% | +112.0% | +0.3% | -15.4% | -5.6% | -16.7% | +16.6% | -36.6% | -6.6% | +9.0% | +48.4% | -16.5% | +42.7% | +0.0% | -23.3% | +5.1% | -14.8% | -20.2% | +8.2% | -3.5% | +14.2% | +5.4% | – | |
| – | +44.2% | -18.7% | +115.6% | -10.9% | -26.3% | -8.2% | +197.5% | -14.6% | -10.5% | -38.0% | -17.6% | +19.0% | -9.4% | +26.5% | +9.4% | -63.0% | +162.5% | -7.7% | +57.0% | -14.3% | +7.3% | -9.2% | -27.1% | +42.3% | -22.7% | +8.3% | +9.0% | -18.2% | +57.4% | -26.2% | +0.0% | +1.2% | +8.7% | -8.3% | -17.8% | +25.6% | -6.9% | -13.9% | +1.6% | – | |
| – | +33.8% | -13.0% | +61.1% | -9.0% | +4.1% | -10.8% | +247.0% | -15.8% | -5.4% | -41.4% | -18.4% | -3.2% | +24.4% | +1.5% | -8.8% | -8.0% | +5.3% | +3.2% | +80.0% | -7.1% | -4.8% | -7.5% | -22.1% | +29.0% | -29.2% | +2.1% | +9.0% | +7.3% | +18.3% | -0.5% | +0.0% | -11.9% | +7.1% | -11.3% | -18.9% | +17.7% | -5.3% | -2.5% | +3.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +42.9% | -10.0% | -59.2% | -19.4% | +0.0% | -100.0% | – | – | -100.0% | – | – | – | – | -8.6% | -40.2% | -83.3% | -38.0% | -47.9% | +59.3% | -12.3% | +82.1% | +0.0% | +2,100.0% | +263.6% | +152.5% | +25.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -1,218.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +44.6% | -896.5% | – | -24.2% | -156.9% | – | – | – | +48.9% | -107.6% | – | – | – | – | – | +8.6% | -119.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -1,218.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.